Literature DB >> 32892960

Autism Spectrum Disorder and Medical Cannabis: Review and Clinical Experience.

Mojdeh Mostafavi1, John Gaitanis2.   

Abstract

Autism spectrum disorder (ASD) is a multifactorial, pervasive neurodevelopmental disorder defined by the core symptoms of significant impairment in social interaction and communication as well as restricted, repetitive patterns of behavior. In addition to these core behaviors, persons with ASD frequently have associated noncore behavioral disturbance (ie, self-injury, aggression), as well as several medical comorbidities. Currently, no effective treatment exists for the core symptoms of ASD. This review reports the available preclinical and clinical data regarding the use of cannabis and cannabidiol in the treatment of core symptoms, noncore symptoms and comorbidities associated with ASD. Additionally, we describe our clinical experience working with children and young adults with ASD who have used cannabis or cannabidiol. At present, preclinical and clinical data suggest a potential for therapeutic benefit among some persons with ASD and that it is overall well tolerated. Further research is required to better identify patients who may benefit from treatment without adverse effects.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32892960     DOI: 10.1016/j.spen.2020.100833

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN: 1071-9091            Impact factor:   1.636


  4 in total

Review 1.  Cannabidiol for the treatment of autism spectrum disorder: hope or hype?

Authors:  João F C Pedrazzi; Frederico R Ferreira; Danyelle Silva-Amaral; Daniel A Lima; Jaime E C Hallak; Antônio W Zuardi; Elaine A Del-Bel; Francisco S Guimarães; Karla C M Costa; Alline C Campos; Ana C S Crippa; José A S Crippa
Journal:  Psychopharmacology (Berl)       Date:  2022-07-29       Impact factor: 4.415

Review 2.  CBD-enriched cannabis for autism spectrum disorder: an experience of a single center in Turkey and reviews of the literature.

Authors:  Serap Bilge; Barış Ekici
Journal:  J Cannabis Res       Date:  2021-12-16

Review 3.  Clinical Data on Canabinoids: Translational Research in the Treatment of Autism Spectrum Disorders.

Authors:  Laura D Carreira; Francisca C Matias; Maria G Campos
Journal:  Biomedicines       Date:  2022-03-29

4.  Paving Plant-Food-Derived Bioactives as Effective Therapeutic Agents in Autism Spectrum Disorder.

Authors:  Natália Cruz-Martins; Cristina Quispe; Celale Kırkın; Ezgi Şenol; Aslı Zuluğ; Beraat Özçelik; Adedayo O Ademiluyi; Olubukola Helen Oyeniran; Prabhakar Semwal; Manoj Kumar; Farukh Sharopov; Victor López; Francisco Les; Iulia-Cristina Bagiu; Monica Butnariu; Javad Sharifi-Rad; Mohammed M Alshehri; William C Cho
Journal:  Oxid Med Cell Longev       Date:  2021-08-21       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.